These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 21781588)

  • 1. [Critics and assessment for guidelines for the prevention of cardiovascular disease in women-2011 update].
    Zhang XF; Hu DY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 May; 39(5):385-6. PubMed ID: 21781588
    [No Abstract]   [Full Text] [Related]  

  • 2. CVD prevention in women: a practice update.
    Campos-Outcalt D
    J Fam Pract; 2011 Jul; 60(7):421-5. PubMed ID: 21731920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease prevention in women: the role of the nurse practitioner in primary care.
    Hoebeke RE
    Crit Care Nurs Clin North Am; 2008 Sep; 20(3):297-304. PubMed ID: 18644512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The female heart is vulnerable to cardiovascular disease: emerging prevention evidence for women must inform emerging prevention strategies for women.
    Wenger NK
    Circ Cardiovasc Qual Outcomes; 2010 Mar; 3(2):118-9. PubMed ID: 20233978
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevent cardiovascular disease in women.
    Holcomb SS
    Nurse Pract; 2004 Jul; 29(7):6-11. PubMed ID: 15238852
    [No Abstract]   [Full Text] [Related]  

  • 6. Guidelines advise against hormone replacement therapy for cardiovascular disease prevention.
    Rollins G
    Rep Med Guidel Outcomes Res; 2001 Aug; 12(17):7-9. PubMed ID: 12296365
    [No Abstract]   [Full Text] [Related]  

  • 7. Heart association issues new guidelines on cardiovascular disease prevention in women.
    Rollins G
    Rep Med Guidel Outcomes Res; 2004 Feb; 15(4):1-2, 6-7. PubMed ID: 15000094
    [No Abstract]   [Full Text] [Related]  

  • 8. Representation of women in randomized clinical trials of cardiovascular disease prevention.
    Melloni C; Berger JS; Wang TY; Gunes F; Stebbins A; Pieper KS; Dolor RJ; Douglas PS; Mark DB; Newby LK
    Circ Cardiovasc Qual Outcomes; 2010 Mar; 3(2):135-42. PubMed ID: 20160159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in prevention: should we screen for risk factors or disease? A current debate in the prevention of cardiovascular events.
    Dennison CR; Hughes S
    J Cardiovasc Nurs; 2009; 24(1):18-20. PubMed ID: 19114796
    [No Abstract]   [Full Text] [Related]  

  • 10. Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan.
    Morimoto T; Fukui T; Lee TH; Matsui K
    Am J Med; 2004 Oct; 117(7):459-68. PubMed ID: 15464702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polish forum for prevention guidelines on cardiovascular diseases prevention in women.
    Kornacewicz-Jach Z; Podolec P; Kopeć G; Pajak A; Zdrojewski T; Naruszewicz M; Stańczyk J; Undas A; Kozek E; Tykarski A; Opala G; Windak A; Torbicki A; Musiał J
    Kardiol Pol; 2007 Mar; 65(3):334-7. PubMed ID: 17615665
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence-based guidelines for cardiovascular disease prevention in women.
    Mosca L; Appel LJ; Benjamin EJ; Berra K; Chandra-Strobos N; Fabunmi RP; Grady D; Haan CK; Hayes SN; Judelson DR; Keenan NL; McBride P; Oparil S; Ouyang P; Oz MC; Mendelsohn ME; Pasternak RC; Pinn VW; Robertson RM; Schenck-Gustafsson K; Sila CA; Smith SC; Sopko G; Taylor AL; Walsh BW; Wenger NK; Williams CL; ; ; ; ; ; ; ; ; ; ; ;
    J Am Coll Cardiol; 2004 Mar; 43(5):900-21. PubMed ID: 14998635
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular disease prevention in women.
    Ganiats TG; Campos-Outcalt D
    Am Fam Physician; 2007 Apr; 75(7):984, 987. PubMed ID: 17427611
    [No Abstract]   [Full Text] [Related]  

  • 14. Summary of the American Heart Association's evidence-based guidelines for cardiovascular disease prevention in women.
    Mosca L; Appel LJ; Benjamin EJ; Berra K; Chandra-Strobos N; Fabumni RP; Grady D; Haan CK; Hayes SN; Judelson DR; Keenan NL; McBride P; Oparil S; Ouyang P; Oz MC; Mendelsohn ME; Pasternak RC; Pinn VW; Robertson RM; Schenck-Gustafsson K; Sila CA; Smith SC; Sopko G; Taylor AL; Walsh BW; Wenger NK; Williams CL;
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):394-6. PubMed ID: 15003972
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary prevention of cardiovascular diseases by lipid-lowering treatment in German general practice: results from GPs ignoring guidelines and risk calculators.
    Oriol-Zerbe C; Abholz HH
    Eur J Gen Pract; 2007; 13(1):27-34. PubMed ID: 17366291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management and prevention of cardiovascular disease in women.
    Price JA
    Nurs Clin North Am; 2004 Dec; 39(4):873-84, xi. PubMed ID: 15561167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular disease prevention tailored for women.
    Engberding N; Wenger NK
    Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1123-34. PubMed ID: 18793115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the risk/benefit profile before recommending aspirin for the primary prevention of cardiovascular events.
    Rodondi N; Bauer DC
    Am J Med; 2004 Oct; 117(7):528-30. PubMed ID: 15464713
    [No Abstract]   [Full Text] [Related]  

  • 19. Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update.
    Genest J; Frohlich J; Fodor G; McPherson R;
    CMAJ; 2003 Oct; 169(9):921-4. PubMed ID: 14581310
    [No Abstract]   [Full Text] [Related]  

  • 20. American Heart Association: council on cardiovascular nursing department.
    Zimmerman L; Carey MG
    J Cardiovasc Nurs; 2007; 22(5):422-4. PubMed ID: 17724425
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.